Market revenue in 2023 | USD 1,539.6 million |
Market revenue in 2030 | USD 2,587.8 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Diagnostic ent devices |
Fastest growing segment | Diagnostic ENT Devices |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Diagnostic ENT Devices, Surgical ENT Devices, Hearing Aids, Hearing Implants, Nasal Splints |
Key market players worldwide | Ambu A/S ADR, Cochlear Ltd, Demant A/S, GN Store Nord A/S, Olympus Corp, RION Co Ltd, Smith & Nephew PLC, Sonova Holding AG, Stryker Corp, Karl Storz, Pentax Medical, Richard Wolf, Starkey, Omnicom Group Inc, NICO, Nemera |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ent devices market will help companies and investors design strategic landscapes.
Diagnostic ent devices was the largest segment with a revenue share of 73% in 2023. Horizon Databook has segmented the China ent devices market based on diagnostic ent devices, surgical ent devices, hearing aids, hearing implants, nasal splints covering the revenue growth of each sub-segment from 2018 to 2030.
Availability of various products in the market due to a number of regional and multinational players, large geriatric population, and high prevalence of ear, nose, & throat related diseases are factors likely to drive the ENT devices market in China.
According to the Cancer Epidemiology report, it was estimated that 285,857 new cases and 132,698 deaths were related to oral and oropharyngeal cancers in China between 2005 and 2013, with mouth and tongue cancers being the most frequently diagnosed and the leading causes of death among all oral and oropharyngeal cancers.
Oropharyngeal and oral cancer incidence rates ranged from 1.69 to 1.89 per 100,000 person-years, and mortality rates ranged from 0.77 per 100,000 person-years and 0.84 per 100,000 person-years, indicating a growing pattern.
Horizon Databook provides a detailed overview of country-level data and insights on the China ent devices market , including forecasts for subscribers. This country databook contains high-level insights into China ent devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account